Some call me Fred or Frederick

📢Novavax / Nuvaxovid availability update As you’ve probably heard, most doses (Lot Nos. 315MF001C and 6315MF002C) expired on December 31st. There is still a batch in circulation with an expiry date of February 28th. We’re still unsure if Novavax/Sanofi will be releasing any more batches for the spring after that. If you’re looking for a pharmacy that has restocked following the Dec. 31st expiry - Anecdotally, I’ve heard more success coming from CVS locations compared to other chains. Reminders, when you’re calling any pharmacy to check for availability: 1. Ask if they’re willing to check the fridge, as new stock will oftentimes go unnoticed by staff. 2. The product is now most commonly being referred to as “Nuvaxovid”, following Novavax’s BLA approval in May 2025. Most people will continue to use the names interchangeably, so make sure that your pharmacy understands that Novavax and Nuvaxovid are the same thing and they’re not confused by the naming (or by the similarity to Moderna’s “Spikevax”). Alternatively, if it works better for them, you can provide them with the National Drug Code (NDC) so they can look up the product in their system. The Nuvaxovid NDC is 80631-207-10 (cartons) or 80631-207-01 (single syringes). 3. Nuvaxovid is still available to order through distributors and through Sanofi’s own portal, VaccineShoppe (vaccineshoppe.com/vsh/en/USD…). Especially let your small, local, and independent pharmacies know if you would like them to place an order. Employees at large pharmacy chains typically lack the authority to place an order for their own store, but still communicate your desire - they can pass the information up the chain, which is important right now as vaccine contracting for the 2026-2027 season will already be getting underway within the next couple of weeks/months. As always, when you show up for an appointment, it’s always best practice to both verbally and visually confirm that you’re actually receiving Novavax. Unfortunately, pharmacies oftentimes make errors, and they’re going to be more common during product rollout periods, periods of increased respiratory illness activity (now), and periods with stock inconsistencies (now, as a result of the Dec. 31st expiry)